Physician

Gaurav Mukesh Shah, MD

According to 2025 Medicare claims, Gaurav Shah, MD (NPI: 1124472337) practices hematology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1114293495; TIN: 56-0529945) and primary practice location at 28211-4369. Shah is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 120 traditional Medicare patients, billed 221 HCPCS/CPT codes, and received $18,301 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 254 prescription claims across 66 beneficiaries totaling $331,049 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 3 records totaling $3,283. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $6,348 to $331,049. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$11K$22K2022 Medicare payment: $5,874 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $22,084 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $18,301 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20224054$5,874
2023108246$22,084
2024120221$18,301

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$381K$763K2017 Drug cost: $6,348 (USD; Tot_Drug_Cst)2018 Drug cost: $3,734 (USD; Tot_Drug_Cst)2019 Drug cost: $179,797 (USD; Tot_Drug_Cst)2020 Drug cost: $762,885 (USD; Tot_Drug_Cst)2021 Drug cost: $544,848 (USD; Tot_Drug_Cst)2022 Drug cost: $89,526 (USD; Tot_Drug_Cst)2023 Drug cost: $77,633 (USD; Tot_Drug_Cst)2024 Drug cost: $331,049 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201721123$6,348
20182251$3,734
20192564$179,797
20201262$762,885
202133142$544,848
20223480$89,526
202358202$77,633
202466254$331,049

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1616$119
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2929$115
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1734$100
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1524$86
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6094$64

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban1145,622$102,436
XareltoRivaroxaban281,320$24,305
Enoxaparin SodiumEnoxaparin Sodium14378$4,751
CyclosporineCyclosporine16363$1,019
HydroxyureaHydroxyurea281,640$395

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$3,283HEMA Biologics, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gaurav Mukesh Shah, MD?

Tedicare shows public-source Medicare data for Gaurav Mukesh Shah, MD (NPI 1124472337), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gaurav Mukesh Shah, MD have ACO affiliation data?

Gaurav Mukesh Shah, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Gaurav Mukesh Shah, MD?

Gaurav Mukesh Shah, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1114293495) in the available physician profile data.

Does Gaurav Mukesh Shah, MD have Open Payments data?

Gaurav Mukesh Shah, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.